Locke J. Bryan, MD | Authors

Releasing the Brake on the Immune System: The PD-1 Strategy for Hematologic Malignancies

June 15, 2015

Incorporation of PD-1 blockade into the treatment algorithms for hematologic malignancies is currently being pursued in multiple active clinical trials. Here we review the data on anti–PD-1 monoclonal antibodies to date and discuss ongoing and future clinical trials.